For research use only. Not for therapeutic Use.
Volagidemab（Cat No.:I042214）is an investigational monoclonal antibody designed to target and inhibit the immune checkpoint receptor VISTA (V-domain Ig Suppressor of T cell Activation). VISTA plays a role in immune suppression within the tumor microenvironment, and by blocking it, volagidemab aims to enhance the body’s immune response against cancer cells. This drug is being studied primarily for its potential in treating various cancers, including solid tumors. Clinical trials are underway to assess its safety, efficacy, and potential combination with other immunotherapies.
| Catalog Number | I042214 |
| CAS Number | 1233956-13-2 |
| Purity | ≥95% |
